These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28169160)

  • 1. Corrigendum to "Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects" [Bioorg. Med. Chem. Lett. 26 (2016) 5724-5728].
    Lombardo M; Bender K; London C; Plotkin MA; Kirkland M; Mane J; Pachanski M; Geissler W; Cummings J; Habulihaz B; Akiyama TE; Di Salvo J; Madeira M; Pols J; Powles MA; Finley MF; Johnson E; Roussel T; Uebele VN; Crespo A; Leung D; Alleyne C; Trusca D; Lei Y; Howard AD; Ujjainwalla F; Tata JR; Sinz CJ
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1333. PubMed ID: 28169160
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects.
    Lombardo M; Bender K; London C; Plotkin MA; Kirkland M; Mane J; Pachanski M; Geissler W; Cummings J; Habulihaz B; Akiyama TE; Di Salvo J; Madeira M; Pols J; Powles MA; Finley MF; Johnson E; Roussel T; Uebele VN; Crespo A; Leung D; Alleyne C; Trusca D; Lei Y; Howard AD; Ujjainwalla F; Tata JR; Sinz CJ
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5724-5728. PubMed ID: 27815121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum to "Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes" Bioorg. Med. Chem. Lett. 28 (2018) [841-846].
    Winters MP; Sui Z; Wall M; Wang Y; Gunnet J; Leonard J; Hua H; Yan W; Suckow A; Bell A; Clapper W; Jenkinson C; Haug P; Koudriakova T; Huebert N; Murray WV
    Bioorg Med Chem Lett; 2018 May; 28(9):1676-1678. PubMed ID: 29605534
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives" [Bioorg Med Chem Lett 27(16) (2017) 3920-3924].
    Suzuki S; Sugawara Y; Tsuji R; Tanimura R; Kaneko C; Yuzawa N; Yagi M; Kawai K
    Bioorg Med Chem Lett; 2019 Feb; 29(3):515. PubMed ID: 30579796
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
    Kang ST; Kim EY; Achary R; Jung H; Park CH; Yun CS; Hwang JY; Choi SU; Chae C; Lee CO; Kim HR; Ha JD; Ryu D; Cho SY
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3205. PubMed ID: 28551102
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000].
    Goncalves MB; Clarke E; Jarvis CI; Kalindjian SB; Pitcher T; Grist J; Hobbs C; Carlstedt T; Jack J; Brown JT; Mills M; Mumford P; Borthwick AD; Corcoran JPT
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2440-2441. PubMed ID: 31208764
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Development of hydrocortisone succinic acid/and 5-fluorouracil/chitosan microcapsules for oral and topical drug deliveries" [Bioorg. Med. Chem. Lett. 22 (2012) 3213-3218].
    Lam PL; Lee KK; Wong RS; Cheng GYM; Cheng SY; Yuen MC; Lam KH; Gambari R; Kok SH; Chui CH
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4607. PubMed ID: 28923534
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1" [Bioorg. Med. Chem. Lett. 26 (2016) 4919-4924].
    Monteillier A; Loucif A; Omoto K; Stevens EB; Lainez S; Saintot PP; Cao L; Pryde DC
    Bioorg Med Chem Lett; 2017 May; 27(9):2082. PubMed ID: 28320618
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core" [Bioorg. Med. Chem. Lett. 26 (2016) 5399-5402].
    Han M; Wang C; Ji Y; Song Z; Xing L; Su Y; Wang X; Zhang A; Ai J; Geng M
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126931. PubMed ID: 31902709
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "A selective delta opioid receptor antagonist based on a stilbene core" [Bioorg. Med. Chem. Lett. 25 (2015) 5532-5535].
    Hartung AM; Navarro HA; Wiemer DF; Neighbors JD
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1645. PubMed ID: 28750745
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay" [Bioorg. Med. Chem. Lett. 25 (2015) 2505-2509].
    Arns S; Tan J; Sun S; Galey A; Zisman N; Ross F; Udechukwu J; Dercho S; Gusti V; Paquette J; Wennekes T; Webb M; Bourque E; Withers SG; Liggins R
    Bioorg Med Chem Lett; 2016 Jul; ():. PubMed ID: 27381085
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "A novel intestinal-restricted FXR agonist" [Bioorg Med Chem Lett 27 (2017) 3386-3390].
    Wang H; Zhao Z; Zhou J; Guo Y; Wang G; Hao H; Xu X
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5353. PubMed ID: 29110987
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477].
    Cooper AB; Ciblat S; Shipps G; Levine J; Kostura M; Oza V; Constantineau-Forget L; Dery M; Grand-Maitre C; Bruneau-Latour N; Bellavance E; Patane M; Siddiqui A; Luther M
    Bioorg Med Chem Lett; 2018 Mar; 28(5):985. PubMed ID: 29433931
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Dimeric sesquiterpene and thiophenes from the roots of Echinops latifolius" [Bioorg. Med. Chem. Lett. 26 (2016) 5995-5998].
    Jin Q; Lee JW; Jang H; Choi JE; Kim HS; Lee D; Hong JT; Lee MK; Hwang BY
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1490. PubMed ID: 28202326
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Challenges in the development of an M
    Tarr JC; Wood MR; Noetzel MJ; Melancon BJ; Lamsal A; Luscombe VB; Rodriguez AL; Byers FW; Chang S; Cho HP; Engers DW; Jones CK; Niswender CM; Wood MW; Brandon NJ; Duggan ME; Jeffrey Conn P; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2018 Sep; 28(17):3014. PubMed ID: 30076050
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres" [Bioorg. Med. Chem. Lett. 24 (2014) 1062-1066].
    Sheffler DJ; Nedelcovych MT; Williams R; Turner SC; Duerk BB; Robbins MR; Jadhav SB; Niswender CM; Jones CK; Conn PJ; Nathan Daniels R; Lindsley CW
    Bioorg Med Chem Lett; 2017 May; 27(9):2079. PubMed ID: 28347668
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Preventive effect of a novel diosgenin derivative on arterial and venous thrombosis in vivo" [Bioorg. Med. Chem. Lett. 26 (2016) 3364-3369].
    Zheng H; Wei Z; Xin G; Ji C; Wen L; Xia Q; Niu H; Huang W
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4386. PubMed ID: 27474444
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to 'Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase' [Bioorg. Med. Chem. Lett. 27 (2017) 1649-1653].
    Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4218. PubMed ID: 28780158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.